L1 Capital International Fund’s Investment in HCA Healthcare (HCA) Paid Off

2 months ago 28

Soumya Eswaran

Fri, Apr 11, 2025, 8:06 AM 3 min read

In This Article:

L1 Capital, an concern absorption firm, released its “L1 Capital International Fund” (unhedged) archetypal 4th 2025 capitalist letter. A transcript of the missive tin beryllium downloaded here. The money returned 0.1% (net of fees) successful the March 4th surpassing the benchmark instrumentality by 2.6% (all successful Australian dollars). The Australian dollar appreciated 1.0% against the U.S. dollar successful the 4th and 3.4% against the Euro. During the archetypal 4th of 2025, the marketplace show by assemblage was mixed. In addition, the missive discussed connected commercialized deficits, Trump administration’s Reciprocal Tariffs, implications of Liberation Day and the displacement successful Trump’s commercialized argumentation and however the steadfast is managing the money successful this volatile environment. Please cheque the fund’s apical 5 holdings to cognize its champion picks successful 2025.

In its archetypal 4th 2025 capitalist letter, L1 Capital International Fund emphasized stocks specified arsenic HCA Healthcare, Inc. (NYSE:HCA). HCA Healthcare, Inc. (NYSE:HCA) owns and operates hospitals and related healthcare entities. The one-month instrumentality of HCA Healthcare, Inc. (NYSE:HCA) was 4.88%, and its shares gained 3.77% of their worth implicit the past 52 weeks. On April 10, 2025, HCA Healthcare, Inc. (NYSE:HCA) banal closed astatine $334.99 per stock with a marketplace capitalization of $82.476 billion.

L1 Capital International Fund stated the pursuing regarding HCA Healthcare, Inc. (NYSE:HCA) successful its Q1 2025 capitalist letter:

"HCA Healthcare, Inc.'s (NYSE:HCA) stock terms partially rebounded successful the March 2025 Quarter, and was the lone institution to positively lend implicit 1% to the Fund’s quarterly returns. We outlined successful the December 2024 Quarterly Report that HCA’s stock terms had implicit reacted to concerns that healthcare argumentation nether the Trump medication would beryllium materially adverse for HCA. We took vantage of the marketplace concerns to adhd to our concern successful HCA astatine a stock terms good beneath our appraisal of just value, and it was pleasing to spot a partial betterment successful the stock terms during the March 2025 quarter. Six different companies each positively contributed 0.5% oregon greater to the Fund’s returns, crossed a divers scope of industries. We judge our unsocial attack to assessing prime businesses of varying size crossed a fig of diversified sectors provides the accidental to present beardown hazard adjusted returns successful a scope of marketplace conditions.


Read Entire Article